Antigens | HPB-AML-I | UCBTERT-21[15] | F6[21] | ISCT criteria[2] | Wang et al.[18] | Lee et al.[22] | Majore et al.[23] |
---|
CD14 | - | - | - | - | - | - | ND |
CD19 | - | ND | ND | - | - | ND | ND |
CD29 | + | + | + | ND | + | ND | ND |
CD34 | - | - | - | - | - | ND | ND |
CD44 | + | + | + | ND | + | + | + |
CD45 | - | - | - | - | - | ND | ND |
CD55 | + | + | ND | ND | ND | ND | ND |
CD59 | + | + | ND | ND | ND | ND | ND |
CD73 | + | ND | ND | + | + | ND | + |
CD90 | - | - | ND | + | ND | + | + |
CD105 | - | ND | ND | + | + | + | + |
CD117 | - | - | ND | ND | ND | ND | ND |
HLA-DR | - | ND | - | - | - | ND | ND |